Oct 27, 2023· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2023-N-3575-0006
The attached comments are submitted on behalf of Consumer Healthcare Products Association (CHPA) on 10/27/2023.
FDANonrulemakingFDA-2023-N-3575
Reauthorization of the Over-the-Counter Monograph Drug User Fee program; Public Meeting; Request for Comments
RIN
—
Last modified
Dec 23, 2024
Comment window
closed 585d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Oct 27, 2023 and Oct 27, 2023. 10 other organizations filed here. The comment window closed 585d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (10)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%
- American Cleaning Institutetrade assoc.2 filings · confidence 85%
- Mead-Raymond Corporationunverified attribution2 filings · confidence 70%
- American Academy of Dermatology Associationtrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Fragrance Creators Associationtrade assoc.1 filing · confidence 85%
- Humane Society of the United States and Humane Society Legislative Fundtrade assoc.1 filing · confidence 85%
- Independent Beauty Associationtrade assoc.1 filing · confidence 85%
- Public Access to SunScreens (PASS) Coalitiontrade assoc.1 filing · confidence 85%
- The Humane Society of the United Statestrade assoc.1 filing · confidence 85%
- The Protecting Access to Pain Relief (PAPR) Coalitiontrade assoc.1 filing · confidence 85%